Pharmacy Times
JULY 3, 2023
All individuals with type 1 diabetes on the therapy had restored insulin secretion, improved glycemic control, improved time-in-range reduction, or elimination of exogenous insulin usage.
STAT
JULY 3, 2023
When the U.S. Supreme Court released its landmark ruling overturning the use of race-conscious college admissions, LaShyra Nolen was on clinical rotation. For Nolen, a fourth-year medical student at Harvard Medical School, the news sent a chill down her spine even though she had been anticipating it. “It felt very lonely,” said Nolen, who is Black and the first in her family to get a bachelors of science degree and attend medical school.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 3, 2023
Using data from a wide-ranging survey of Medicare enrollees, investigators found that using value weights from participants would have a negative impact on smaller, rural hospitals.
Pharmaceutical Technology
JULY 3, 2023
Pipeline developments within the obesity space have recently garnered interest following recent results published on Eli Lilly’s retatrutide.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JULY 3, 2023
The study also found significant evidence of outcomes disparities between minority populations and White populations.
STAT
JULY 3, 2023
DENVER — The founder of Field Trip , a chain of shuttered ketamine clinics currently facing insolvency, put forward an unexpected theory of how psychedelics work to treat depression last month. “The truth is, almost all of the effect of psychedelic-assisted therapy could be placebo,” said Ronan Levy, speaking at a five-day conference on the emerging field of psychedelic medicine.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JULY 3, 2023
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: Novo Nordisk is conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease.
European Pharmaceutical Review
JULY 3, 2023
Positive topline data has been revealed from the pivotal ELATIVE ® Phase III trial of elafibranor , an investigational dual α,δ PPAR agonist for primary biliary cholangitis (PBC). Data showed 51 percent of patients on 80mg of the small molecule treatment elafibranor achieved a cholestasis response compared with four percent on placebo. The Phase III trial enrolled 161 patients.
STAT
JULY 3, 2023
LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading. Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study.
Drug Store News
JULY 3, 2023
The AI-powered skin care line comprises more than 15 million possible formula combinations that can target multiple skin concerns simultaneously.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JULY 3, 2023
For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin. “We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer,
Pharmaceutical Technology
JULY 3, 2023
2023 started with a buzz around ChatGPT, and more generally around the immense potential that generative AI (GenAI) holds.
STAT
JULY 3, 2023
Five years from now, when patients walk into a doctor’s office presenting symptoms of almost any condition you can envision — whether migraine, multiple sclerosis, or obesity — their physician will offer a new kind of treatment plan that involves both pharmaceutical-based medication and a prescription digital therapeutic. Accessible through the patient’s smartphone, the digital therapeutic will deliver personalized, evidence-based interventions to treat their conditio
Drug Store News
JULY 3, 2023
Retailers that leverage up-to-date and in-depth insights on in-store habits can tailor their strategies to best service today’s customers.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
JULY 3, 2023
China has granted approval for Innovent Biologics and IASO Bio Fucaso for treating relapsed or refractory multiple myeloma (RRMM) in adults.
Outsourcing Pharma
JULY 3, 2023
George Freeman MP, minister of state at the new Department for Science, Innovation and Technology, has praised a decade of growth at Discovery Park, the leading science and innovation campus in Sandwich, Kent.
Drug Store News
JULY 3, 2023
It’s Like Skin 2-in-1 Concealer + Tint is designed to brighten and blur the skin for a naturally radiant finish, the company said.
Pharmaceutical Technology
JULY 3, 2023
Madrigal Pharmaceuticals has commenced a rolling submission of an NDA seeking expedited approval from the US FDA for resmetirom.
Drug Store News
JULY 3, 2023
Retail pharmacies could reclaim success by proactively addressing three of today’s most significant challenges.
Pharmacy Times
JULY 3, 2023
The collaboration will focus on engaging with health experts and opinion leaders to examine data to gain a better understanding of the role continuous glucose monitoring systems have in personalized therapeutic nutrition.
Outsourcing Pharma
JULY 3, 2023
RAIR Health, an applied data and AI company focused on the extraction of clinical insights from real world data, has signed a non-exclusive data license agreement with Royal Cornwall Hospitals NHS Trust (RCH) focussed on the field of ophthalmology.
Drug Store News
JULY 3, 2023
As part of the #HerestotheFarmer campaign, Bayer will be the presenting sponsor for Luke Bryan’s 2023 Farm Tour.
OctariusRx
JULY 3, 2023
Let Freedom Ring! From all of us at OctariusRx, Happy Independence Day! Thank you to all who serve or have served our Nation in pursuit of the freedom we enjoy today and every day! “We’re blessed with the opportunity to stand for something, for liberty and fairness. And these are things worth fighting for, worth devoting our lives to.” – Ronald Reagan The Consultant Pharmacists at OctariusRx provide guidance on safe medication management, survey readiness and cost savings to a
Drug Store News
JULY 3, 2023
Retail pharmacies could reclaim success by proactively addressing three of today’s most significant challenges.
Pharmacy Times
JULY 3, 2023
Less than half of respondents would recommend a vaccine against respiratory syncytial virus to a pregnant friend or family member.
Drug Store News
JULY 3, 2023
The Spot Detergent sheets are free from parabens and phosphates, the company said.
Pharmaceutical Technology
JULY 3, 2023
The bioscience company has received $10m Series A financing from asset manager Mercia.
Drug Store News
JULY 3, 2023
AAM said in its white paper that recent reports suggest a rise in shortages in 2023.
Outsourcing Pharma
JULY 3, 2023
Kicking off a series of DIA Global interviews in Boston, OSP had the pleasure of speaking to Cal Collins, co-founder and CEO of OpenClinica - a company that wants to empower data managers, clinical researchers, and study participants.
pharmaphorum
JULY 3, 2023
Australia first to prescribe MDMA and psilocybin for depression, PTSD Nicole.
The Guardian - Pharmaceutical Industry
JULY 3, 2023
Shares close down 8% on concerns that new lung cancer drug may not be as successful as hoped Nearly £14bn has been wiped off the stock market value of AstraZeneca over concerns that a new lung cancer drug may not be as successful as had been hoped. Shares in the Anglo-Swedish pharmaceutical company closed down 8% on Monday after it published the first results from its phase 3 trial for datopotamab deruxtecan, making it the biggest faller among FTSE 100 companies.
Drug Store News
JULY 3, 2023
A new survey from Del Monte Foods reveals new insights into snacking habits.
pharmaphorum
JULY 3, 2023
AZ, Daiichi’s TROP2 drug hits the mark in lung cancer Phil.
Pharmafile
JULY 3, 2023
Reacta Healthcare, an early-stage food allergy diagnostic company, has announced the appointment of Kevin Hawkins as head of regulatory affairs. Hawkins has extensive leadership experience including in R&D, regulatory affairs, analytical development and project leadership, having previously worked as senior director and head of development at Teva Pharmaceuticals for more than ten years.
Expert insights. Personalized for you.
123 
Let's personalize your content